Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1. Leukemia 2018 Sep;32(9):2032-2036
Date
03/24/2018Pubmed ID
29568098Pubmed Central ID
PMC6127091DOI
10.1038/s41375-018-0091-3Scopus ID
2-s2.0-85044287939 (requires institutional sign-in at Scopus site) 11 CitationsAuthor List
Garderet L, Laubach JP, Stoppa AM, Hari P, Cavo M, Ludwig H, Mateos MV, Luptakova K, Lin J, Yung G, van de Velde H, Berg D, Moreau P, Richardson PGAuthor
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antineoplastic Combined Chemotherapy ProtocolsDrug Resistance, Neoplasm
Humans
Kaplan-Meier Estimate
Multiple Myeloma
Prognosis
Proportional Hazards Models
Randomized Controlled Trials as Topic
Recurrence
Retreatment
Treatment Outcome
